Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LABCORP HOLDINGS INC.LH · Entity 1277 | EVP, CHRO | March 26, 2026 | March 30, 2026 |
| V F CORPVFC · Entity 3887 | EVP, CHRO & Public Affairs | October 18, 2022 | October 25, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LABCORP HOLDINGS INC.
Report date March 26, 2026 · Filed March 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,185 |
Ending reported balance
After 2026-03-26 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-26 · Grant · Acquired 6,604 · Balance 8,064 F1: Shares acquired on March 26, 2026, pursuant to a performance award granted on April 5, 2023, relating to performance during the three-year period ended December 31, 2025. Row 2 · 2026-03-26 · Tax withholding · Disposed 2,879 · Balance 5,185 F2: Stock withholding to satisfy tax withholding obligations. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired on March 26, 2026, pursuant to a performance award granted on April 5, 2023, relating to performance during the three-year period ended December 31, 2025.
F2: Stock withholding to satisfy tax withholding obligations.
V F CORP
Report date October 18, 2022 · Filed October 25, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Commom StockSEC Table I · non-derivative | Direct | 52,538.708 |
Reported balance
Holding disclosure · report date 2022-10-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 52,538.708 |
| Commom StockSEC Table I · non-derivative | IndirectLiving Trust | 6,508 |
Reported balance
Holding disclosure · report date 2022-10-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 6,508 |
| 2015 Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.98 · Expires 2025-02-17 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-18 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F1: This option vests as follows: 8506 shares vested on 02/18/2016; 8506 shares vested on 02/18/2017; and 8505 shares vested on 02/18/2018. |
| 2016 Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.92 · Expires 2026-02-22 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-18 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F2: This option vests as follows: 10,761 shares vested on 02/23/2017; 10,761 shares vested on 02/23/2018; and 10,762 shares vested on 02/23/2019. |
| 2019 Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.47 · Expires 2028-02-20 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-18 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F3: This option vests as follows: 9992 shares vested on 02/21/2019; 9992 shares vested on 02/21/2020; and 9990 shares vested on 02/21/2021. |
| FY 2020 Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $84.23 · Expires 2029-05-23 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-18 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance Not disclosed F4: This option vests as follows: 9293 shares vested on 05/24/2020; 9292 shares vested on 05/24/2021; and 9292 shares vested on 05/24/2022. |
| FY 2021 Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.74 · Expires 2030-05-18 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-18 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance Not disclosed F5: This option vests as follows: 11,083 shares vested on 05/19/2021; 11,082 shares vested on 05/19/2022; and 11,082 shares vest on 05/19/2023. |
| FY 2022 Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.78 · Expires 2031-05-24 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-18 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance Not disclosed F6: This option vests as follows: 9921 shares vested on 05/25/2022; 9921 shares vest on 05/25/2023; and 9920 shares vest on 05/25/2024. |
| FY 2023 Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.34 · Expires 2032-05-23 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-18 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance Not disclosed F7: This option vests as follows: 16,653 shares vest on 05/24/2023; 16,653 shares vested on 05/24/2024; and 16,653 shares vested on 05/24/2025. |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests as follows: 8506 shares vested on 02/18/2016; 8506 shares vested on 02/18/2017; and 8505 shares vested on 02/18/2018.
F2: This option vests as follows: 10,761 shares vested on 02/23/2017; 10,761 shares vested on 02/23/2018; and 10,762 shares vested on 02/23/2019.
F3: This option vests as follows: 9992 shares vested on 02/21/2019; 9992 shares vested on 02/21/2020; and 9990 shares vested on 02/21/2021.
F4: This option vests as follows: 9293 shares vested on 05/24/2020; 9292 shares vested on 05/24/2021; and 9292 shares vested on 05/24/2022.
F5: This option vests as follows: 11,083 shares vested on 05/19/2021; 11,082 shares vested on 05/19/2022; and 11,082 shares vest on 05/19/2023.
F6: This option vests as follows: 9921 shares vested on 05/25/2022; 9921 shares vest on 05/25/2023; and 9920 shares vest on 05/25/2024.
F7: This option vests as follows: 16,653 shares vest on 05/24/2023; 16,653 shares vested on 05/24/2024; and 16,653 shares vested on 05/24/2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2026 Filed Mar 30, 2026 16:57 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 2,879 | $268.38 | $772,666.02 |
DisclosureSEC source: 0000920148-26-000125 · form4.xml · nonDerivative · entry 2 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,185 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 16:57 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantCommon Stock | 6,604 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000125 · form4.xml · nonDerivative · entry 1 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,064 F1 · kind: Shares acquired on March 26, 2026, pursuant to a performance award granted on April 5, 2023, relating to performance during the three-year period ended December 31, 2025. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 18:09 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 356 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000082 · form4.xml · derivative · entry 3 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,401 Underlying: Common Stock · 356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 18:09 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 109 | $289.89 | $31,598.01 |
DisclosureSEC source: 0000920148-26-000082 · form4.xml · nonDerivative · entry 2 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,460 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 18:09 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000082 · form4.xml · nonDerivative · entry 1 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:35 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 1,360 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000062 · form4.xml · derivative · entry 2 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,757 Underlying: Common Stock · 1,360 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 20:35 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantNon-qualified Stock Options · Derivative | 4,100 | $0.00 Strike: $284.50 | $0.00 |
DisclosureSEC source: 0000920148-26-000062 · form4.xml · derivative · entry 1 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2036-02-09 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 09, 2026 Filed Feb 10, 2026 20:01 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 112 | $274.01 | $30,689.12 |
DisclosureSEC source: 0000920148-26-000023 · form4.xml · nonDerivative · entry 4 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,213 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2026 Filed Feb 10, 2026 20:01 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 367 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000023 · form4.xml · derivative · entry 6 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,397 Underlying: Common Stock · 367 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested. F5 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2026 Filed Feb 10, 2026 20:01 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 367 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000023 · form4.xml · nonDerivative · entry 3 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 20:01 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 327 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000023 · form4.xml · derivative · entry 5 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,764 Underlying: Common Stock · 327 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 20:01 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 119 | $277.20 | $32,986.80 |
DisclosureSEC source: 0000920148-26-000023 · form4.xml · nonDerivative · entry 2 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 958 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 20:01 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 327 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000023 · form4.xml · nonDerivative · entry 1 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 16:28 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 1,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-004535 · form4.xml · derivative · entry 2 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,091 Underlying: Common Stock · 1,070 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 16:28 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantNon-qualified Stock Options · Derivative | 3,200 | $0.00 Strike: $245.14 | $0.00 |
DisclosureSEC source: 0001127602-25-004535 · form4.xml · derivative · entry 1 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200 Underlying: Common Stock · 3,200 shares Expires 2035-02-10 F1 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:06 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 369 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003712 · form4.xml · derivative · entry 6 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,021 Underlying: Common Stock · 369 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:06 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 119 | $246.27 | $29,306.13 |
DisclosureSEC source: 0001127602-25-003712 · form4.xml · nonDerivative · entry 4 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2025 Filed Feb 10, 2025 14:06 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 369 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003712 · form4.xml · nonDerivative · entry 3 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 14:06 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 326 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003712 · form4.xml · derivative · entry 5 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,390 Underlying: Common Stock · 326 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 14:06 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 118 | $247.74 | $29,233.32 |
DisclosureSEC source: 0001127602-25-003712 · form4.xml · nonDerivative · entry 2 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 14:06 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 326 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003712 · form4.xml · nonDerivative · entry 1 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 20:19 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 369 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003955 · form4.xml · derivative · entry 5 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,716 Underlying: Common Stock · 369 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F7 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F8 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 20:19 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Tax withholdingCommon Stock | 107 | $223.71 | $23,936.97 |
DisclosureSEC source: 0001127602-24-003955 · form4.xml · nonDerivative · entry 2 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 20:19 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 369 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-003955 · form4.xml · nonDerivative · entry 1 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 20:19 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantNon-qualified Stock Options · Derivative | 3,000 | $0.00 Strike: $222.28 | $0.00 |
DisclosureSEC source: 0001127602-24-003955 · form4.xml · derivative · entry 4 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2034-02-05 F5 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F6 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 20:19 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 980 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003955 · form4.xml · derivative · entry 3 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,085 Underlying: Common Stock · 980 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 115 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 18:50 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 990 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-012716 · form4.xml · derivative · entry 2 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 990 Underlying: Common Stock · 990 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 18:50 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantNon-qualified Stock Options · Derivative | 3,000 | $0.00 Strike: $234.01 | $0.00 |
DisclosureSEC source: 0001127602-23-012716 · form4.xml · derivative · entry 1 GRAHAM ANITA Z · CIK 0001206814 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2033-04-04 F1 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.